ATE338142T1 - Methoden zur diagnose und behandlung von herzkrankheiten - Google Patents
Methoden zur diagnose und behandlung von herzkrankheitenInfo
- Publication number
- ATE338142T1 ATE338142T1 AT01902063T AT01902063T ATE338142T1 AT E338142 T1 ATE338142 T1 AT E338142T1 AT 01902063 T AT01902063 T AT 01902063T AT 01902063 T AT01902063 T AT 01902063T AT E338142 T1 ATE338142 T1 AT E338142T1
- Authority
- AT
- Austria
- Prior art keywords
- methods
- heart disease
- diagnosis
- treatment
- treat
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 5
- 208000019622 heart disease Diseases 0.000 title abstract 4
- 238000003745 diagnosis Methods 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 2
- 238000012216 screening Methods 0.000 abstract 2
- 206010019280 Heart failures Diseases 0.000 abstract 1
- 238000010171 animal model Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/461—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from fish
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Analytical Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Toxicology (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Cardiology (AREA)
- Pathology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hospice & Palliative Care (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Heart & Thoracic Surgery (AREA)
- Veterinary Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US17578700P | 2000-01-12 | 2000-01-12 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE338142T1 true ATE338142T1 (de) | 2006-09-15 |
Family
ID=22641625
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT01902063T ATE338142T1 (de) | 2000-01-12 | 2001-01-12 | Methoden zur diagnose und behandlung von herzkrankheiten |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US20020182599A1 (de) |
| EP (1) | EP1254260B1 (de) |
| JP (1) | JP2003533179A (de) |
| AT (1) | ATE338142T1 (de) |
| AU (1) | AU785046B2 (de) |
| CA (1) | CA2396330A1 (de) |
| DE (1) | DE60122673T2 (de) |
| WO (1) | WO2001051666A1 (de) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2002103355A1 (fr) * | 2001-06-18 | 2002-12-27 | Takeda Chemical Industries, Ltd. | Agents prophylactiques/remedes pour maladies cardiaques |
| EP1463820A4 (de) * | 2001-12-17 | 2007-09-05 | Childrens Medical Center | Verfahren zum screening von verbindungen |
| AU2003293141A1 (en) * | 2002-11-25 | 2004-06-18 | Sequenom, Inc. | Methods for identifying risk of breast cancer and treatments thereof |
| US7608458B2 (en) * | 2004-02-05 | 2009-10-27 | Medtronic, Inc. | Identifying patients at risk for life threatening arrhythmias |
| WO2005078452A1 (en) | 2004-02-05 | 2005-08-25 | Medtronic, Inc. | Methods and apparatus for identifying patients at risk for life threatening arrhythmias |
| US8027791B2 (en) * | 2004-06-23 | 2011-09-27 | Medtronic, Inc. | Self-improving classification system |
| US8335652B2 (en) * | 2004-06-23 | 2012-12-18 | Yougene Corp. | Self-improving identification method |
| US20050287574A1 (en) * | 2004-06-23 | 2005-12-29 | Medtronic, Inc. | Genetic diagnostic method for SCD risk stratification |
| US20070179815A1 (en) * | 2006-01-20 | 2007-08-02 | Heartscreen America, Inc. | Medical screening system and method |
| WO2009044459A1 (ja) * | 2007-10-02 | 2009-04-09 | Fujitsu Limited | 分析支援プログラム、分析支援装置、および分析支援方法 |
| US20090136954A1 (en) * | 2007-11-14 | 2009-05-28 | Medtronic, Inc. | Genetic markers for scd or sca therapy selection |
| US20110143956A1 (en) * | 2007-11-14 | 2011-06-16 | Medtronic, Inc. | Diagnostic Kits and Methods for SCD or SCA Therapy Selection |
| EP2430184A2 (de) * | 2009-05-12 | 2012-03-21 | Medtronic, Inc. | Sca-risikostratifizierung durch vorhersage des ansprechens von patienten auf antiarrhythmika |
| WO2012142159A2 (en) * | 2011-04-11 | 2012-10-18 | The Brigham And Women's Hospital, Inc | Structural mutations in titin cause dilated cardiomyopathy |
-
2001
- 2001-01-12 DE DE60122673T patent/DE60122673T2/de not_active Expired - Lifetime
- 2001-01-12 JP JP2001551240A patent/JP2003533179A/ja active Pending
- 2001-01-12 US US09/759,508 patent/US20020182599A1/en not_active Abandoned
- 2001-01-12 AU AU27907/01A patent/AU785046B2/en not_active Ceased
- 2001-01-12 CA CA002396330A patent/CA2396330A1/en not_active Abandoned
- 2001-01-12 EP EP01902063A patent/EP1254260B1/de not_active Expired - Lifetime
- 2001-01-12 AT AT01902063T patent/ATE338142T1/de not_active IP Right Cessation
- 2001-01-12 WO PCT/US2001/001212 patent/WO2001051666A1/en not_active Ceased
-
2003
- 2003-09-05 US US10/656,873 patent/US20040265841A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| AU785046B2 (en) | 2006-09-07 |
| US20040265841A1 (en) | 2004-12-30 |
| WO2001051666A1 (en) | 2001-07-19 |
| US20020182599A1 (en) | 2002-12-05 |
| EP1254260A1 (de) | 2002-11-06 |
| EP1254260A4 (de) | 2003-07-23 |
| AU2790701A (en) | 2001-07-24 |
| CA2396330A1 (en) | 2001-07-19 |
| EP1254260B1 (de) | 2006-08-30 |
| DE60122673D1 (de) | 2006-10-12 |
| JP2003533179A (ja) | 2003-11-11 |
| DE60122673T2 (de) | 2007-07-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69921156D1 (de) | Verwendung von 5ht-6 antagonisten zur behandlung adhd | |
| ATE338142T1 (de) | Methoden zur diagnose und behandlung von herzkrankheiten | |
| ATE440536T1 (de) | Verfahren zur diagnose, behandlung und prävention von knochenverlust | |
| DE60329165D1 (de) | Detektion und/oder beobachtung von synuclein-assoziierten krankheiten | |
| DE60108230D1 (de) | Vorrichtung für diagnose und behandlung von arrhytmien | |
| ATE453653T1 (de) | Platinkomplexe zur behandlung von tumoren | |
| ATE182180T1 (de) | Lamanin-ketten: diagnostische und therapeutische verwendung | |
| ATE311226T1 (de) | Die glycin-betain für seine antithrombotische verwendung | |
| DE60230877D1 (de) | Behandlung von muskeldystrophien und verwandter erkrankungen | |
| DE60126248D1 (de) | Verwendung von brustkrebs membranproteine für behandlung, prophylaxe und diagnose von brustkrebs | |
| EP1550462A4 (de) | MITTEL ZUR BEHANDLUNG ODER PRûVENTION VON NIERENERKRANKUNGEN UND VERFAHREN ZUR DIAGNOSE VON NIERENERKRANKUNGEN | |
| ATE446285T1 (de) | Für die behandlung von alzheimer-krankheit und ähnlichen leiden geeignete 1-alkyl-3- thiosubstituierte indol-2-alkinsäuren | |
| ATE356995T1 (de) | Verfahren zur identifizierung von mitteln zur behandlung von diabetes | |
| EP1363528A4 (de) | Verfahren zur diagnose und behandlung von herzerkrankungen | |
| ATE290857T1 (de) | Bretyliumhaltige zusammensetzungen und kits und deren verwendung zur vorbeugung und behandlung cardiovaskulärer erkrankungen | |
| DE60111620D1 (de) | Aktiviertes protein c zur behandlung von pankreatitis | |
| ATE393785T1 (de) | Glykopeptide, deren herstellung und verwendung in der diagnose oder behandlung von multipler sklerose | |
| ATE494903T1 (de) | Verwendung von slurp-1 zur behandlung von krankheiten, die durch störungen der acetylcholinerezeptoren ausgelöst werden | |
| WO2003028536A3 (en) | Methods for diagnosing and treating heart disease | |
| DE60225845D1 (de) | Zusammensetzungen und verfahren zur diagnose und behandlung von diabetes, insulinresistenz und dyslipidämie | |
| ATE339690T1 (de) | Verfahren zum screening von verbindungen auf aktivität bei der behandlung einer mit osteoklasten zusammenhängenden knochenerkrankung | |
| DE69905489D1 (de) | Protein c zur behandlung von sichelzellanämie und thalassämie | |
| ATE414539T1 (de) | Verfahren und materialien zur behandlung und diagnose von mit kallikrein-6 zusammenhängenden entzündlichen zuständen | |
| ATE258064T1 (de) | Verwendung von antileukoprotease zur behandlung von endometriose | |
| CY1110278T1 (el) | Μεθοδος διαλογης παραγοντων ικανων να θεραπευουν την παχυσαρκια |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |